Breast Cancer-Related Small-Molecule Inhibitors and Their Mechanisms of Action
Breast cancer exhibits marked molecular heterogeneity. Different subtypes may develop distinct molecular features, including sustained HER2 receptor activation, enhanced PI3K-AKT signaling, uncontrolled cell-cycle progression, defects in DNA damage repair, glutamine metabolic dependence, and ...
危险品化学品经营许可证（带存储）